The immunoprotective activity of Klebsiella pneumoniae K2 cell surface preparations and purified capsular polysaccharide was tested in mice. The 50% protective dose (PD50), expressed as capsular polysaccharide content, was 2 ng for cell surface preparations and 50 ng for purified capsular polysaccharide. Both preparations lost their immunoprotective activity after alkali treatment. Immune sera were raised in rabbits immunized with cell surface preparations. The precipitating and hemagglutinating capacity of these antisera was tested against either purified capsular polysaccharide or alkali-treated capsular polysaccharide. No difference was observed between the reactivity of the antisera against each antigen. The protective activity of these sera was tested on mice in passive transfer experiments, before and after absorption with either purified capsular polysaccharide or alkali-treated capsular polysaccharide. The sera lost their protective activity after absorption with purified capsular polysaccharide and after absorption with alkali-treated capsular polysaccharide. These experiments show that the difference in immunoprotective activity of cell surface preparations, purified capsular polysaccharide, and alkali-treated capsular polysaccharide is not due to a difference in their antigenic determinants. Cell surface preparations and purified capsular polysaccharide were fractionated by gel filtration on Sepharose 4B and by ultracentrifugation on cesium chloride density gradients. 
Nosocomial infections due to Klebsiella pneumoniae remain an important cause of morbidity and mortality (8) . Several epidemiological studies (6, 41, 45) have shown the predominance of serotypes K2 and K21 among the 77 Klebsiella capsular serotypes identified (38) . K. pneumoniae capsular polysaccharide (CP) has also been shown to be essential for the virulence of this bacterium in animal models (13, 14) .
The immunoprotective activity of antibodies directed against K. pneumoniae CP has been demonstrated. These antibodies have been elicited in response to immunization with inactivated whole cells (7) , ribosomal preparations (42, 44) , cell surface preparations (CSP) (15) , and purified CP (9, 12) .
The protective activity of K. pneumoniae K2 CP ( Fig. 1 ) against challenge with live Klebsiella has been quantified after active immunization of mice (15) . The 50% protective dose (PD50) of CP varies dramatically depending on whether the CP was purified or included in CSP. The PD50 of CSP-included CP is only 2 ng (15) , while the PD50 of purified CP varies considerably from batch to batch. Some batches of purified CP do not protect mice, even at an immunizing dose of 30 ,ug (15) , while other batches have a PD50 of 50 ng (unpublished data).
Two hypotheses could explain the different levels of protection induced by K. pneumoniae CP, either purified or included in CSP. (i) Highly immunoprotective preparations express antigenic determinants which are not present in lowor nonprotective preparations. (ii) CSP-included CP is immunogenic either because its association with other constituents of CSP (protein, lipopolysaccharide [LPS] ) which could have adjuvant activity or because a native form of CP exists in CSP which allows it to express its immunogenicity.
The first hypothesis was examined by studying the precipitation and hemagglutinating and protective activity of sera from rabbits immunized with K. pneumoniae CSP and absorbed with purified nonimmunoprotective CP. To study the second hypothesis, we compared the protective activity of CP and CSP before and after fractionation by gel filtration and cesium chloride density gradient ultracentrifugation. alkali-treated CSP (Alk-CSP) and alkali-treated CP (Alk-CP) were freeze-dried.
Gel ifitration. Gel filtration was performed on a CL-4B Sepharose (Pharmacia Fine Chemical) column (2.5 by 72 cm) equilibrated in 0.01 M Tris hydrochloride buffer containing 0.01 M EDTA and 0.02% (wt/vol) sodium azide (pH 8.0). Elution was carried out with the same buffer with a flow rate of 15 mlIh, and 5-ml fractions were collected. The void volume was measured with blue dextran (Pharmacia); sodium azide was used for determination of the total volume of the column.
After dialysis against distilled water, the protein, LPS, and CP content of each fraction was determined by biochemical assays. Each peak was characterized by its coefficient of distribution (Kd). The fractions of each peak were pooled, dialyzed against phosphate-buffered saline, and stored at -20°C. The protein, LPS, and CP content of each peak was determined by biochemical assays before immunization of mice.
Cesium chloride density gradient ultracentrifugation. Density gradient ultracentrifugation was performed at 60,000 rpm for 72 h at 4°C in an SW25.1 rotor (Beckman Instruments Inc.). CsCl solution initial densities of 1.400, 1.658, 1.678, and 1.760 g/cm3 were used. The gradient was fractionated from the top of the centrifuge tube, and 1-ml fractions were collected. The protein content of each fraction was determined by its absorbance at 280 nm. LPS and CP were detected in each fraction by immunodiffusion as previously described (15) . The CP content of each fraction was also determined by biochemical assay of uronic acid. Each peak was characterized by its density. The fractions of each peak were pooled, dialyzed against distilled water, and stored at -20°C. The protein, LPS, and CP content of each peak was determined by biochemical assays before immunization of mice.
Biochemical assays. Protein was determined by the method of Lowry et al. (33) , and bovine serum albumin served as the standard. RNA and nucleotidic components were evaluated spectrophotometrically (29) or by the orcinol method (1). Yeast RNA (Sigma Chemical Co.) served as the standard. K. pneumoniae CP was determined by measuring the amount of uronic acid by the method of Blumenkrantz and AsboeHansen (5), assuming that K2 CP contains 26% glucuronic acid (16) . Glucuronic acid (Sigma) served as the standard.
LPS was measured either in vitro by the carbocyanin dye method of Janda and Work (21) or in vivo in mice sensitized with actinomycin D (Sigma) by the method of Pieroni et al. (39) . Salmonella enteritidis LPS (Difco Laboratories, Detroit, Mich.; no. 3126) served as the standard.
Antisera. Three rabbits were immunized with 500-,ug amounts (protein) of CSP emulsified in Freund complete adjuvant. The first dose was injected intradermally in the back. The rabbits were boosted by four intramuscular injections (100 ,ug of protein) at 14-day intervals with antigen emulsified in Freund complete adjuvant. The rabbits were bled 10 days after the last injection.
Immunodiffusion. Agarose (0.6%) in saline was used for immunodiffusion assays. The antigen concentrations used were 0.2 to 0.4 mg/ml for CSP and 50 ,ug/ml for CP and Alk-CP.
Quantitative precipitin test. The method used to quantitate precipitin was that of Heidelberger and Kendall, as described by Kabat and Mayer (23) . Increasing amounts of antigen were added to constant volumes, usually 100 ,ul, of antiserum. The mixtures were incubated for 1 h at 37°C and kept for 3 days at 4°C. The immunoprecipitates, separated by centrifugation, were washed three times with cold saline and dissolved by adding 0.1 N NaOH. The antibody protein in the precipitate was determined by the method of Lowry et al. (33) .
Sensitization of sheep erythrocytes. CP and Alk-CP were coupled to sheep erythrocytes by the method of Baker et al. (2) . One-milliliter suspensions of 0.15 M NaCl containing 600 ,ug of either CP or Alk-CP were added to 0.5 ml of pellets of packed, washed sheep erythrocytes. This concentration of antigen has been found to optimally sensitize sheep erythrocytes. Then, 1.0 ml of 0.1% chromium chloride (CrCl3 * 6H20) was added, and the mixture was allowed to stand at 25°C for 5 min. Sensitized sheep erythrocytes (SSE) were washed three times with 0.15 M NaCl. SSE were used as packed cells for absorption experiments and as a 0.5% cell suspension in 0.15 M NaCl for hemagglutination.
Hemagglutination. Hemagglutination was performed in microtitration plates. Reactions were read after 2 h at 37°C. The titers are expressed as the reciprocal of the highest serum dilution yielding a positive agglutination. Positive and negative controls were included with the test.
Absorption of serum. Serum was inactivated by heating at 56°C for 30 min and then absorbed with either CP or Alk-CP. Absorption was done in two steps. In the first step, the serum was absorbed with the soluble antigen at the concentration giving the maximum precipitation (equivalence), as determined by quantitative precipitin analysis. In the second step, the serum was absorbed with SSE. A 5-ml amount of serum was added to 0.5 ml of packed SSE. After 3 h of incubation at 4°C with frequent mixing, the suspension was centrifuged at 750 x g for 15 min. The absorbed serum was Immunization and challenge. Mice were immunized subcutaneously with 0.5 ml of the vaccine preparation diluted in sterile pyrogen-free saline. Immunizing doses were expressed by the CP content of the vaccine. Control mice were inoculated subcutaneously with 0.5 ml of sterile pyrogenfree saline.
All mice were challenged intraperitoneally with 100 LD50 of K. pneumoniae 14 days after immunization. The bacterial count at the time of the challenge was confirmed by the spread plaque technique. Deaths, which occurred principally between days 2 and 8, were recorded 14 days after challenge. PD50 were calculated by the Reed-Muench formula (40) .
Passive transfer of serum. Normal mice received 0.2 ml of rabbit serum via the lateral tail vein. All recipients, plus a control group injected with saline, were challenged intraperitoneally with 100 LD50 of K. pneumoniae 24 h after transfer.
RESULTS
Chemical composition of antigens. CP contained 3% protein, 1% LPS, and 1% nucleotidic components. CSP contained 39% protein, 32% CP, 26% LPS, and 3% nucleotidic components. Alkali treatment of CP and CSP did not significantly alter their composition. LPS contained less than 1% protein and nucleotidic components.
Immunoprotective activity. Groups of mice were immunized with CSP, CP, and with each preparation treated with alkali. The control group received saline. All animals were challenged 14 days later with 100 LD50 of K. pneumoniae. CSP were highly immunoprotective, since their PD50, expressed by the CP content, was 2 ng. Purified CP was less active, with a PD50 of 50 ng. After alkali treatment of CP and CSP, no protective activity was observed, since their PD50 were greater than 10 ,ug.
Antigenic activity. The antigenic activity of CP and Alk-CP was tested with rabbit antisera. No difference was observed in the immunodiffusion patterns of CP and Alk-CP reacting with anti-CSP immune sera (data not shown). The hemagglutination titers of the anti-CSP rabbit sera were the same when determined with either CP-SSE or Alk-CP-SSE. Precipitation analysis of one anti-CSP rabbit serum was done with CP and Alk-CP. The identity of the precipitation curves of both preparations is shown in Fig. 2 .
Absorption studies. Anti-CSP rabbit sera were first absorbed with either soluble CP or soluble Alk-CP. The antigens were used at the concentration giving maximum precipitation, as determined by the precipitation curve. After absorption with either CP or Alk-CP, the sera did not precipitate the corresponding polysaccharide. The hemagglutination titer of the anti-CSP sera, which was pneumoniae CP is involved in the immunoprotective activity of antigenic preparations extracted from this bacterium (15) .
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The second group of CP we identified contains some batches of purified CP and one fraction of the CP isolated from CSP by CsCl density gradient centrifugation. This fraction was not associated with protein and LPS and sedimented at the same density (1.7 to 1.8 g/cm3) as purified CP. These CP preparations had an intermediate immunoprotective activity (PD50 = 50 ng). The difference between the high protective activity of CSP-included CP and the intermediate protective activity of purified CP could be due to the removal of LPS and protein during the purification and the resulting loss of their adjuvant effect.
The third group of CP is characterized by the absence of protective activity, even at the high immunizing dose of 10 ,ug. The nonprotective CP fraction, obtained by gel filtration of CSP, had a high Kd (0.75), and this result agrees with the observation that the immunogenicity of polysaccharides is partly dependent on their molecular weight (18, 22) . However, the fact that alkali treatment of purified CP suppressed its immunoprotective activity without changing its Kd is surprising. The stability of the Kd after alkali treatment means that the molecular weight of the polysaccharide was not altered. However, alkali treatment of CP could have affected other physicochemical characteristics of the molecule, such as conformation, which could be critical to the expression of its immunogenicity.
In summary, these experiments show that the difference in immunoprotective activity of K. pneumoniae K2 CSP, CP, and Alk-CP is not due to a difference in their antigenic determinants. A detailed analysis of the structure of the different preparations of K. pneumoniae we described here will be required to achieve a better knowledge of the mechanisms accounting for the expression of their immunogenic properties.
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